Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11 C]DASB
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The serotonin transporter (5-HTT) plays a critical role in the regulation of serotonin neurotransmission and has been implicated in the pathophysiology of major depression. In a previous positron emission tomography study, we found no difference in brain 5-HTT binding between unmedicated recovered depressed patients and healthy controls.
This study aims to assess brain 5-HTT binding in a group of unmedicated acutely depressed patients in comparison to healthy controls.
We studied 5-HTT binding using [11C]DASB in conjunction with positron emission tomography in 12 medication-free depressed patients with a mean duration of illness of about 1 year and 24 healthy controls.
The depressed patients had lowered 5-HTT binding in several brain regions including brain stem, thalamus, caudate, putamen, anterior cingulate cortex and frontal cortex.
These results suggest that diminished availability of the 5-HTT in the brain may be a state marker of acute depression. Alternatively, low 5-HTT binding may delineate a group of depressed patients with a poor long-term prognosis.
- Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB
Volume 213, Issue 2-3 , pp 555-562
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Serotonin transporter
- Mood disorder
- Industry Sectors
- Author Affiliations
- 1. University Department of Psychiatry, Warneford Hospital, Oxford, UK
- 2. Medical Research Council Cyclotron Unit, Hammersmith Hospital, London, UK
- 3. GSK CIC, Imperial College London, London, UK
- 4. Department of Psychiatry, Yale University, Newhaven, USA
- 5. Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK